Optimization of Ultra-High-Throughput Screening Assay for Protein Engineering of D-Allulose 3-Epimerase

A better enzyme starts with a better screen

Enzyme performance decides the cost of D-allulose. That matters to buyers. D-Allulose is the C-3 epimer of D-fructose. It tastes and sweetens like sucrose. The enzyme that makes it, D-allulose 3-epimerase (DAEase), determines yield and process temperature. Wild-type DAEase often lacks the heat tolerance a production plant needs.

This paper, published in Biomolecules, takes on that weakness. The researchers optimized a PsiR-based ultra-high-throughput screening assay. Then they used that assay to evolve DAEase into a much more stable catalyst.

Why screening bottlenecks DAEase evolution

Directed evolution only works when you can sort through many mutants quickly. Plate-based assays are slow in comparison. An ultra-high-throughput screen changes the economics. It lets you test larger libraries and find the rare variants that improve real production traits.

The team’s screening method produced exactly that. It led to the single mutant I228V, which came with better specific activity and better thermostability. That is not a small result. Many directed evolution campaigns end with tradeoffs—more activity, less stability. This one found a mutation that improved both.

What the study did

The optimized screen did its job. It identified I228V. The final triple mutant I228V/D281G/C289R is the variant that matters.

Specific activity rose to 1.42 times that of wild-type. The half-life at 60°C extended 62.97-fold. Think about what that means in a process. You can hold the reaction at higher temperatures without dumping in extra enzyme every few hours.

Key findings

The most practical result came from the biosynthesis run. At 70°C, the triple mutant converted D-fructose to D-allulose at 28.11%. Wild-type reached only 21.64%.

Metric	Wild-type DAEase	Triple mutant I228V/D281G/C289R
Relative specific activity	1.0	1.42
Half-life at 60°C	baseline	62.97× longer
D-Fructose conversion at 70°C	21.64%	28.11%

These two improvements happened together. Many enzymes gain activity and lose stability. This variant gained both. That is rare.

What this means for manufacturers

Ask your enzyme supplier how they screen DAEase variants. Suppliers who rely on older plate-based methods may not have explored the sequence space thoroughly. A supplier using high-throughput directed evolution can find mutants like I228V and build on them. For buyers, that translates into a more consistent enzyme supply and a lower cost per kilogram of D-allulose.

The triple mutant also opens process options. Running at 70°C helps with solubility and lowers the risk of microbial contamination. It also makes continuous processing more realistic. A stable enzyme can be reused or kept in the reactor longer. That is a direct operating cost advantage.

Of course, pilot data will tell the real story. Lab conversion numbers do not guarantee plant performance. But they provide a benchmark. If an enzyme supplier offers a DAEase with this mutation profile, request data under your own conditions. You need to test pH, feed purity, and enzyme loading before scaling up.

FAQ

How much did the triple mutant improve activity and stability? Specific activity rose to 1.42 times wild-type. Half-life at 60°C was 62.97 times longer.

Is the mutant better at high-temperature conversion? Yes. At 70°C, the triple mutant converted 28.11% of D-fructose, versus 21.64% for wild-type.

Should formulators change specifications now? Not yet. This is research-stage evidence. Use it to start conversations with enzyme suppliers and to evaluate new DAEase preparations as they arrive.

Where this leaves you

This paper sets a new benchmark for DAEase evolution. It also shows the value of the right screen. For allulose producers, the path to lower cost starts with asking for better enzymes. Now there is a defined mutant to request, test, and compare.